A 50% tissue culture infective dose (TCID50) assay was performed to assess viral titration and infectivity. On day 0, MARC-145 cells were seeded in a 96-well plate at a density of 1 × 104 cells per well. On day 1, the cells were inoculated with serially 10-fold diluted viruses at 37°C for 1 h. The excess virus inoculum was removed by washing the cells with PBS. Maintenance medium (2% FBS–DMEM; 200 μl) was added to each well, and the cells were cultured for a further 3 to 5 days. Cells showing the expected cytopathic effect were counted daily, and the TCID50 value was calculated with the Reed-Muench method (75). Each assay was performed in triplicate.
(i) Intracellular infectivity. Cells were washed three times with PBS, scraped, and pelleted by centrifugation at 1,000 × g for 5 min. The cell pellets were subjected to three cycles of freeze-thawing with liquid nitrogen and a thermal block set to 37°C. The cell lysates were centrifuged at 10,000 × g for 10 min at 4°C to remove the cell debris. The titers of infectious virus were expressed as TCID50 per milliliter after a limiting-dilution assay.
(ii) Extracellular infectivity. To determine the extracellular infectivity of the virus, the supernatants were harvested, filtered through a 0.45-μm-pore-size filter, and stored at 4°C. Their infectivity was determined in parallel with a limiting-dilution assay, as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.